Rivus Pharmaceuticals Stock
HealthTechLooking to sell Rivus Pharmaceuticals stock or options?
Rivus Pharmaceuticals develops controlled metabolic accelerators aimed at enhancing cardio-metabolic health. The company focuses on improving cellular metabolism and addressing the root causes of common metabolic and cardiovascular diseases. They offer patients oral small-molecule therapeutics that target the fundamental metabolic risk factors contributing to cardiovascular mortality and morbidity.
Investors Include:
RA Capital Management, Medicxi, RxCelerate, Bain Capital Life Sciences, BB Biotech, Longitude Capital.